NERV (NASDAQ: NERV) Form 144 shows 156,410-share sale, 650,000 offered

Rhea-AI Filing Summary

NERV submitted a Form 144 reporting a proposed resale of 650,000 shares of Common Stock. The filing also records an actual sale of 156,410 shares on 03/10/2026 for $1,191,767.01. The excerpt lists 43,274,396 shares outstanding as of 03/31/2026.

Key Figures

Registered/offered amount: 650,000 shares Shares sold (past 3 months): 156,410 shares Proceeds from recent sale: $1,191,767.01 +1 more

4 metrics

Registered/offered amount 650,000 shares Securities To Be Sold line dated 04/15/2015

Shares sold (past 3 months) 156,410 shares Sale reported on 03/10/2026

Proceeds from recent sale $1,191,767.01 Cash proceeds shown for 03/10/2026 sale

Shares outstanding 43,274,396 shares Listed as of 03/31/2026

Key Terms

Form 144, Secondary Offering/Open Market, Shares outstanding, Proceeds

4 terms

Form 144 regulatory

"Securities To Be Sold | 04/15/2015 | Secondary Offering/Open Market"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Secondary Offering/Open Market market

"Securities To Be Sold | 04/15/2015 | Secondary Offering/Open Market"

Shares outstanding financial

"43274396 | 03/31/2026 | NASDAQ Common Stock"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

Proceeds financial

"156410 | 1191767.01"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Canaccord Genuity, Inc. 1 Penn Plaza 30th Floor New York NY 10119	31808	254464.00	43274396	03/31/2026	NASDAQ
Common Stock	Instinet, Inc. 309 West 49th Street New York NY 10019	31808	254464.00	43274396	03/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/15/2015	Secondary Offering/Open Market	Unknown			650000	04/15/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Federated Hermes Kaufmann Fund 4000 Ericsson Drive Warrendale PA 15086	Common Stock	03/10/2026	156410	1191767.01

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does NERV's Form 144 report?

It reports a proposed resale of 650,000 shares and a recent sale of 156,410 shares. The filing lists the sale date 03/10/2026 and the proceeds shown as $1,191,767.01.

How many shares did NERV sell during the past three months?

The filing shows a sale of 156,410 shares on 03/10/2026. The reported cash proceeds for that sale are $1,191,767.01, as shown in the excerpt.

What registered offering amount appears on the Form 144 for NERV?

The form lists a proposed resale quantity of 650,000 shares under 'Securities To Be Sold' dated 04/15/2015. The line is presented as a secondary/open market offering.

Does the filing state outstanding shares for NERV?

Yes; the excerpt lists 43,274,396 shares outstanding as of 03/31/2026. That figure appears in the securities/cover data included in the provided text.

Who appears as the broker(s) listed on the Form 144?

The excerpt names brokers including Canaccord Genuity, Inc. and Instinet, Inc., with addresses shown on the securities lines in the filing text.